BSECompany Update24 Aug 2026 · 24 Aug 2026, 07:23 pm
Appointment of Mr. Suraj Mahadev Gaikwad (DIN: 11159369) as Additional Director (Independent and Non-Executive) of the Company to hold the office up to the date of the ensuing Annual General ....
Eiko Lifesciences Ltd · 540204
✦ AI SummaryMgmt Change
Eiko Lifesciences Ltd has appointed Mr. Suraj Mahadev Gaikwad as Additional Director (Independent and Non-Executive) to hold the office up to the date of the ensuing Annual General Meeting of the Company, and thereafter as an Independent Director of the Company for a term of 5 (five) years, subject to the approval of shareholders.
Analysis Scores
Earnings Impact2/10
Growth Catalyst3/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk1/10
Liquidity Impact5/10
Market Sentiment5/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Eiko Lifesciences Ltd - 540204 - Announcement under Regulation 30 (LODR)-Change in Management
Attachments (1)
📄pdf
Download →
0df83913-8c11-4c57-b3df-37728878d12e.pdf
View document text
Date: 24th August, 2026
Corporate Services Department,
BSE Limited,
Phiroze Jeejeebhoy Towers,
1st Floor, Dalal Street,
Fort, Mumbai - 400001.
Scrip Code: 540204
Subject: Appointment of Additional Director (Independent and Non-Executive)
Ref. : Outcome of the Board Meeting held on 24th August, 2026
Dear Sir/Madam,
Pursuant to the Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and
Disclosure Requirements) Regulations, 2015 (“Listing Regulations”), and amendments thereto, this is to
inform that the Meeting of the Board of Directors of the Company held today i.e., on Monday, 24th August,
2026, Board, inter-alia, considered the following:
1. Approved appointment of Mr. Suraj Mahadev Gaikwad (DIN: 11159369) as Additional Director
(Independent and Non-Executive) of the Company to hold the office up to the date of the ensuing
Annual General Meeting of the Company, and thereafter as an Independent Director of the
Company for a term of 5 (five) years, subject to the approval of shareholders.
Details as required under SEBI Master Circular No. HO/49/14/14(7)2025-CFD-POD2/I/3762/2026
dated 30th January 2026 is attached herewith as Annexure A
Please take the same on your records.
For Eiko Lifesciences Limited
Chintan Doshi
Company Secretary and Compliance Officer
Membership No: A 36190
Eiko LifeSciences Limited, CIN: L65993MH1977PLC258134
Registered Address: 604, Centrum, Opp. TMC Office, Near Satkar Grande Hotel, Wagle Estate, Thane MH 400604
Mobile No.: +919082668855; Email id: investor.rela(cid:415)ons@eikolifesciences.com website: www.eikolifesciences.com
ANNEXURE – A
Brief details of Appointment of Mr. Suraj Mahadev Gaikwad (DIN: 11159369) as Additional Director
(Independent and Non-Executive)
Details as required under SEBI Master Circular No. HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated
30th January 2026 are annexed herewith.
Sr. No Particular Details
1. Reason for change viz. Appointment of Mr. Suraj Mahadev Gaikwad as
appointment, Resignation, Additional Independent and Non-Executive Director of
removal, death or otherwise; the Company.
2. Date of Appointment 24th August, 2026
3. Term of Appointment Appointment of Mr. Suraj Mahadev Gaikwad as
Additional Director (Independent and Non-Executive) of
the Company to hold the office up to the date of the
ensuing Annual General Meeting of the Company, and
thereafter as an Independent Director of the Company
for a term of 5 (five) years, subject to the approval of
shareholders.
4. Qualification & brief profile (in case Mr. Suraj Mahadev Gaikwad is Commerce Graduate,
of appointment) having more than 7 years of experience in accountancy
and business Management. He brings extensive
knowledge and diverse expertise to his professional
endeavors, contributing meaningfully to financial
operations and strategic planning.
His strong background in the accountancy sector
positions him as a valuable asset in supporting the
organization’s strategic goals and enhancing overall
operational efficiency and compliance structure.
5. Disclosure of relationship between None
Directors (in case of appointment
of Director)
6. Affirmation as required pursuant to Mr. Suraj Mahadev Gaikwad is not debarred from
BSE Circular with ref. no. holding the office of director on account of any order
LIST/COMP/14/2018-19 dated 20th of SEBI or any other such authority
June, 2018.
Eiko LifeSciences Limited, CIN: L65993MH1977PLC258134
Registered Address: 604, Centrum, Opp. TMC Office, Near Satkar Grande Hotel, Wagle Estate, Thane MH 400604
Mobile No.: +919082668855; Email id: investor.rela(cid:415)ons@eikolifesciences.com website: www.eikolifesciences.com